VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SISIShineco, Inc.
$0.30$1352
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSISIP/E History

SISI logoShineco, Inc. (SISI) P/E Ratio History

Deep Value

Trading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2017–2019

Current P/E (TTM)
-0.0x
-100% vs 5Y avg
5Y Avg P/E
9.8x
Median 7.2x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-0.0x
Min3.2xMedian7.2xMax23.9x
TTM EPS$-123.94
Price$0.30
Earnings YieldN/A
EPS Growth (1Y)41.1%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 23, 2026, Shineco, Inc. (SISI) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.30 and trailing twelve-month earnings per share of $-123.94.

The current P/E is 100% below its 5-year average of 9.8x. Over the past five years, SISI's P/E has ranged from a low of 3.2x to a high of 23.9x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, SISI trades at a 100% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, SISI trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SISI DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

SISI Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.0vs22.1
-100%
Below Sector
vs. S&P 500
-0.0vs24.3
-100%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 41% EPS growth (1Y)

SISI P/E vs Peers

Traditional Chinese medicine producers peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
SIEB logoSIEBSiebert Financial Corp.
$75M14.22.46-61%
TSN logoTSNTyson Foods, Inc.
$20B40.8--40%
SYY logoSYYSysco Corporation
$37B20.90.39-4%
VITL logoVITLVital Farms, Inc.
$432M7.0Lowest0.18Best+22%Best

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

SISI Historical P/E Data (2017–2019)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2019 Q4Jun 30 2019$81060.00$3982.1420.4x+107%
FY2019 Q2Dec 31 2018$69600.00$20600.683.4x-66%
FY2019 Q1Sep 30 2018$119990.00$35656.893.4x-66%
FY2018 Q4Jun 30 2018$201600.00$38895.285.2x-47%
FY2018 Q3Mar 31 2018$194400.00$60212.053.2x-67%
FY2018 Q2Dec 31 2017$276000.00$46866.835.9x-40%
FY2018 Q1Sep 30 2017$310800.00$43015.497.2x-27%
FY2017 Q4Jun 30 2017$361200.00$44083.718.2x-17%
FY2017 Q3Mar 31 2017$559200.00$39167.5814.3x+45%
FY2017 Q2Dec 31 2016$504000.00$38219.6513.2x+34%
FY2017 Q1Sep 30 2016$999999.00$41888.9223.9x+143%

Average P/E for displayed period: 9.8x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

9+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SISI — Frequently Asked Questions

Quick answers to the most common questions about buying SISI stock.

What is SISI's P/E ratio?

Shineco, Inc. (SISI) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-123.94. The 5-year average P/E is 9.8x and the historical range spans 3.2x to 23.9x.

Is SISI stock overvalued or undervalued?

SISI current P/E: -0.0x. 5-year average P/E: 9.8x. Percentile: 0th.

Is SISI stock expensive?

SISI is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 9.8x (0th percentile of historical range).

What is SISI's historical P/E range?

Over the past 5 years, SISI's P/E ratio has ranged from 3.2x to 23.9x, with a median of 7.2x and an average of 9.8x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2017–2019.

How does SISI's P/E compare to the S&P 500?

SISI current P/E: -0.0x. S&P 500 median P/E: 24.3x.

How does SISI's valuation compare to Healthcare peers?

Shineco, Inc. P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.

What is SISI's PEG ratio?

SISI PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of 41.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is SISI's earnings yield?

SISI earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

SISI P/E Ratio History (2017–2019)

Quarterly valuation multiple from closing price and trailing EPS

Current20.4x
Period Avg9.8x
Range3.2x - 23.9x
Change-15%
11 quartersSep 30, 2016 - Jun 30, 2019